Covered recipient · General Payments record
MARLENE E MIRES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,590.20
- Reported across 185 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.85 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $48.69 | 3 |
| Lilly USA, LLC | $37.56 | 2 |
| Merck Sharp & Dohme Corporation | $34.00 | 1 |
| Novo Nordisk AS | $27.14 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.48 | 1 |
| Acerta Pharma LLC | $15.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $15.98 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105555542 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.48 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117926222 | CMS |
| GlaxoSmithKline, LLC. | $14.85 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116286595 | CMS |
| GlaxoSmithKline, LLC. | $13.77 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116689092 | CMS |
| GlaxoSmithKline, LLC. | $20.07 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116583011 | CMS |
| Lilly USA, LLC | $22.91 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135179707 | CMS |
| Lilly USA, LLC | $14.65 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135179709 | CMS |
| Merck Sharp & Dohme LLC | $34.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141646225 | CMS |
| Novo Nordisk Inc | $27.14 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097528334 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.